n-isobutyrylcysteine has been researched along with alpha-synuclein in 1 studies
| Studies (n-isobutyrylcysteine) | Trials (n-isobutyrylcysteine) | Recent Studies (post-2010) (n-isobutyrylcysteine) | Studies (alpha-synuclein) | Trials (alpha-synuclein) | Recent Studies (post-2010) (alpha-synuclein) |
|---|---|---|---|---|---|
| 12 | 1 | 4 | 10,821 | 29 | 8,011 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, R; Gao, G; He, M; Li, J; Sun, T; Wang, L | 1 |
1 other study(ies) available for n-isobutyrylcysteine and alpha-synuclein
| Article | Year |
|---|---|
Gold nanoclusters for Parkinson's disease treatment.
Topics: alpha-Synuclein; Animals; Antiparkinson Agents; Cysteine; Disease Models, Animal; Gold; Male; Mice, Inbred C57BL; Nanoparticles; Parkinson Disease; PC12 Cells; Rats | 2019 |